What “Simponi patent drugs” could mean (and how to check the right products)
The term “Simponi patent drugs com” looks like a search for Simponi (golimumab) patent information, likely via DrugPatentWatch.com or similar databases. Simponi is a brand for golimumab, a biologic, and “patent drugs” usually refers to which drugs are covered by related patents, who holds them, and when key exclusivities/patents end.
If you meant “Simponi patent drugs” on DrugPatentWatch.com, the fastest path is to search for “Simponi (golimumab)” there and then review the patents listed for the specific product (brand vs. biosimilar/alternate formulations). (DrugPatentWatch is commonly used for this kind of patent mapping.) [1]
When Simponi exclusivity/patents typically end (the practical timeline people search for)
People usually want to know two dates:
1) When marketing exclusivity ends (so other companies can sell a biosimilar in that country), and
2) When later-expiring patents end (which can delay launches even after exclusivity ends).
For biologics, the relevant blocking can come from multiple patent families (formulation, method-of-use, manufacturing, etc.), not a single “expiration date.” That’s why you’ll often see multiple patent entries for the same biologic on patent-tracking sites. Checking the specific Simponi product page on DrugPatentWatch helps match the exact patents and expiration estimates/indicators for that jurisdiction. [1]
How patents can affect biosimilar entry for golimumab
Even when a biosimilar is approved, patent litigation or remaining patent coverage can affect when it actually launches. If you’re looking for “patent drugs” because you want to know whether a biosimilar can compete, the key questions are usually:
- Which patents are still listed as active/expiring latest?
- Are there “orange book style” exclusivity signals (in the US context) and/or listed biosimilar-related court actions?
- Are there patents specific to a formulation or indication?
A patent tracker page tied to Simponi (golimumab) helps surface which patents are the likely bottlenecks. [1]
What to search for if you meant “Simponi patent drugs com” as a competitor/biosimilar question
If your goal is to find “what other drugs compete with Simponi” while patents are active, the typical search is “golimumab biosimilar” plus “patent” and the country (US/EU/UK/etc.). Patent mapping sites will often link to related competitors and biosimilars, but you still have to verify:
- approval status in your country
- launch date (if any)
- whether patents were cleared or are still in force
If you meant a specific link: tell me the exact country (and whether you meant DrugPatentWatch)
Patent answers depend heavily on country and product variant (for example, US vs. EU, and which Simponi presentation). If you paste the exact URL you’re trying to reach or tell me:
- country (US/EU/UK/etc.)
- whether you mean Simponi vs. Simponi Aria
- whether you want “expiration dates” or “which patents block biosimilars”
…I can give a tighter, specific answer.
Sources:
[1] https://www.drugpatentwatch.com/